Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,902 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of patient-reported outcomes and clinical characteristics among patients with pituitary macroadenomas and giant adenomas.
Miller JE, Chung HR, Uy BR, Kosaraju N, Shih RM, Ko M, Esswein SR, Abiri A, Khosravi P, Huck N, Nguyen CH, Hsu T, Kim MG, Hsu FPK, Kim W, Lee JK, Suh JD, Bergsneider M, Kuan EC, Wang MB. Miller JE, et al. Among authors: kim w. Int Forum Allergy Rhinol. 2024 Apr 22. doi: 10.1002/alr.23354. Online ahead of print. Int Forum Allergy Rhinol. 2024. PMID: 38646913
IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
Vadevoo SMP, Kang Y, Gunassekaran GR, Lee SM, Park MS, Jo DG, Kim SK, Lee H, Kim WJ, Lee B. Vadevoo SMP, et al. Among authors: kim wj. Theranostics. 2024 Apr 8;14(6):2605-2621. doi: 10.7150/thno.92672. eCollection 2024. Theranostics. 2024. PMID: 38646639 Free PMC article.
All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis.
Rao A, Zhang X, Cillo AR, Sussman JH, Sandlesh P, Tarbay AC, Mallela AN, Cardello C, Krueger K, Xu J, Li A, Xu J, Patterson J, Akca E, Angione A, Jaman E, Kim WJ, Allen J, Venketeswaran A, Zinn PO, Parise R, Beumer J, Duensing A, Holland EC, Ferris R, Bagley SJ, Bruno TC, Vignali DAA, Agnihotri S, Amankulor NM. Rao A, et al. Among authors: kim wj. bioRxiv [Preprint]. 2024 Apr 13:2024.04.09.588752. doi: 10.1101/2024.04.09.588752. bioRxiv. 2024. PMID: 38645178 Free PMC article. Preprint.
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Lee SH, Oh S, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Jeong YH, Park Y, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Lee JH, Yoo SY, Ahn Y; OPTION-STEMI Investigators Gwangju, Korea; Suncheon, Korea; Jeonju, Korea; Seoul, Korea; Jinju, Korea; Wonju, Korea; Gwangmyeong, Korea; Changwon, Korea; Bucheon, Korea; Uijeongbu, Korea; Daegu, Korea; Pyeongtaek, Korea; Gangneung, Korea. Kim MC, et al. Among authors: kim w. Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.03.017. Online ahead of print. Am Heart J. 2024. PMID: 38641031
18,902 results
You have reached the last available page of results. Please see the User Guide for more information.